Research in New York
- 1 of 3
- next ›
Biopharmaceutical research companies are conducting or have conducted more than 6,200 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the 6,282 clinical trials, 3,255 target or have targeted the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
These 6,282 New York-based clinical trials represent approximately one-third of all clinical trials in the United States.